Jean-Pierre Crinelli
Founder presso NOVACYT
Patrimonio netto: 18 974 $ in data 31/03/2024
Profilo
Jean-Pierre Crinelli is the founder of Novacyt SAS, where he holds the title of Independent Non-Executive Director starting in 2006.
He currently holds positions as a Non-Executive Director at Novacyt UK Holdings Ltd., Manager at SCI Padapi, and Member-Management Board at Alain Fresard Technologies-Micromecanique.
He formerly held the position of Chairman at CUP 92 SAS.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NOVACYT SAS
0.05% | 31/12/2022 | 33 981 ( 0.05% ) | 18 974 $ | 31/03/2024 |
Posizioni attive di Jean-Pierre Crinelli
| Società | Posizione | Inizio |
|---|---|---|
| NOVACYT | Founder | 03/07/2006 |
| SCI Padapi | Corporate Officer/Principal | - |
| Alain Fresard Technologies-Micromecanique | Corporate Officer/Principal | - |
Novacyt UK Holdings Ltd.
 Novacyt UK Holdings Ltd. BiotechnologyHealth Technology Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The private company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy. | Director/Board Member | - |
Precedenti posizioni note di Jean-Pierre Crinelli
| Società | Posizione | Fine |
|---|---|---|
CUP 92 SAS
 CUP 92 SAS Medical SpecialtiesHealth Technology CUP 92 SAS operates as a holding company with interest in the provision of solutions in cytology and molecular biology fields. The company was founded on March 11, 2010 and is headquartered in Compiegne, France. | Chairman | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NOVACYT | Health Technology |
| Aziende private | 4 |
|---|---|
CUP 92 SAS
CUP 92 SAS Medical SpecialtiesHealth Technology CUP 92 SAS operates as a holding company with interest in the provision of solutions in cytology and molecular biology fields. The company was founded on March 11, 2010 and is headquartered in Compiegne, France. | Health Technology |
| SCI Padapi | |
| Alain Fresard Technologies-Micromecanique | |
Novacyt UK Holdings Ltd.
Novacyt UK Holdings Ltd. BiotechnologyHealth Technology Part of Novacyt SAS, Novacyt UK Holdings Ltd. is a diagnostics company that develops tests that detect infections. The private company is based in Eastleigh, UK. The British company was founded in 2019. The CEO is James Martin Mccarthy. | Health Technology |
- Borsa valori
- Insiders
- Jean-Pierre Crinelli
